One-stage Bilateral Procedure Research Articles

One-stage bilateral anterior bikini total hip replacement - experience of two cases.

Bilateral hip arthrosis is commonly seen and two-staged bilateral Total Hip Arthroplasty (THA) is a preferred choice of treatment due to the fear of complications associated with one-stage bilateral procedures. However, many studies now indicate that the treatment option should be patient specific. We report two cases of one-stage bilateral anterior THA. First, a 54-year-old male operated over a year ago and second a 59-year-old female operated 6 weeks ago. Both presented with a long history of bilateral grade IV hip arthritis causing them severe pain, compromised gait and disturbed sleep. Post-surgery, they were mobilized within few hours after surgery as part of our enhanced recovery programme. There was a drastic increase in their Harris Hip Scores from 34.5 in case 1 and 19.2 in case 2 to 100 for both hips in both patients. They reported excellent recovery, regained normal gait pattern, returned quickly to their routine lifestyle and felt it was an economical option. We conclude that one-stage bilateral bikini anterior THA is a preferred surgical option for patients with bilateral hip arthritis that are medically fit.

One-stage bilateral implantation of acalcar-guided short-stem intotal hip arthroplasty : Minimally invasive modified anterolateral approach in supine position.

ObjectiveOne-stage bilateral, muscle-preserving, calcar-guided implantation technique through the modified minimally invasive anterolateral approach in supine position.IndicationsBilateral primary/secondary osteoarthritis of the hip; bilateral femoral head necrosis; ASA I–III.ContraindicationsASA IV; severe osteoporosis, other factors jeopardizing stable anchorage of cementless, calcar-guided short-stem; infection.Surgical techniqueSupine position. Skin incision. Opening of fascia; blunt dissection, pushing gluteal muscles dorsally with the index finger. Capsulectomy. Individual osteotomy according to preoperative plan to determine short-stem position. Remove femoral head. Prepare acetabulum. Position cup. Femoral preparation with the curved opening awl. Spare greater trochanter and gluteal muscles. Insert trial rasps in ascending sizes with “round-the-corner” technique. Select offset version, then trial reposition with intraoperative radiograph and implantation of the definitive implant. Wound closure. Consultation with the anesthesiologist to confirm a stable patient. Same procedure on contralateral hip.Postoperative managementMobilization on day 1 with immediate full weight bearing. Remove wound drains and urinary catheter (only female patients) on day 2. Intensive protocol of physiotherapy and rehabilitation. Thrombosis prophylaxis. Rehabilitation from day 7.ResultsAlmost 500 patients have undergone surgery since 2010. First consecutive 54 patients (108 hips) prospectively evaluated. After 2 years, Harris Hip Score was 98.8; satisfaction on visual analogue scale was 9.9. Low peri- and postoperative complication rates; no implant revisions.ConclusionThe muscle-sparing approach and the special “round-the-corner” technique in one-stage bilateral procedure leads to rapid mobilization and rehabilitation with excellent early clinical results and high satisfaction rates.

The role of the emphysema multidisciplinary team in a successful lung volume reduction surgery programme†.

Lung volume reduction surgery (LVRS) for advanced emphysema is well established, with strong evidence from the National Emphysema Treatment Trial. However, there is still reluctance to offer the procedure, and many have looked for alternative, unproven treatments. The multidisciplinary approach has been well established in treatment of lung cancer and, more recently, in coronary artery surgery. We reviewed our practice to validate the role of our multidisciplinary team approach in our LVRS programme. Our multidisciplinary approach employs respiratory physicians, radiologists and surgeons involved in case selection, who meet on a regular basis. Cases are selected on the basis of clinical presentation, imaging (radionuclide lung perfusion and computerized tomography) and respiratory physiology. Retrospective analysis of prospectively collected data on 633 patients referred for lung volume reduction surgery between July 1995 and July 2013. Six hundred and thirty-three patients (422 male) were referred for LVRS, of whom 253 [178 male; median age 61 years (range 37-79 years)] underwent 292 LVRS procedures.There were 268 video-assisted thoracoscopic surgical procedures, of which 13 were one-stage bilateral procedures and 37 required a staged second side. Overall median hospital stay was 13 (4-197) days, during which 11 patients died. Prolonged hospital stay was associated with increasing age and with duration of air leak, which in turn was associated with diffusion capacity and forced expiratory volume in 1 s. The outcomes of a successful LVRS programme are not only dependent on good surgical technique and post-operative care. Case selection and work-up by a dedicated multidisciplinary approach for emphysema patients plays an invaluable and integral part in an LVRS programme.

Video-Assisted Sympathectomy for Essential Hyperhidrosis

Essential hyperhidrosis is characterized by overactivity of the sympathetic fibers passing through the upper-dorsal ganglia (second and third thoracic ganglia [D2-D3]), and the treatment of choice is video-assisted thoracoscopy sympathectomy. Alterations in cardiopulmonary function after treatment have been reported.To evaluate cardiopulmonary function impairment after sympathectomy in patients with essential hyperhidrosis.Prospective controlled trial at a pulmonary function unit of a university hospital.Twenty patients (2 men and 18 women) with essential hyperhidrosis.Pulmonary function tests, including spirometry and thoracic gas volume, bronchial challenge with methacholine, and maximal exercise, were performed before and 3 months after D2-D3 sympathectomy. Video-assisted sympathectomy was performed using a one-stage bilateral procedure with electrocoagulation of D2-D3 ganglia. Pulmonary function values (spirometrics and volumes) were not statistically different in the two groups. The maximal midexpiratory flow was the only variable that showed significant changes, from 101% (SD, 26%) to 92% (SD, 27%) [p < 0.05]. Ten patients had positive bronchial challenge test results that remained positive 3 months after surgery, and 2 patients whose challenge test results were negative before surgery became positive after sympathectomy. Significant reductions in maximal heart rate (HR) and oxygen and carbon dioxide uptakes were observed during the maximal exercise test.Video-assisted thoracoscopy is a safe treatment, and the observed modifications in cardiopulmonary function only suggest a minimal small airway alterations in the presence of positive bronchial hyperresponsiveness and mild sympathetic blockade in HR. The clinical importance of these findings is not significant.

Prophylaxis against Deep Venous Thrombosis after Total Knee Arthroplasty. Pneumatic Plantar Compression and Aspirin Compared with Aspirin Alone*

A prospective, randomized study was conducted to assess the efficacy of pulsatile pneumatic plantar compression for prophylaxis against deep venous thrombosis after total knee arthroplasty performed with use of regional anesthesia. One hundred and twenty-two patients (164 knees) who were scheduled to have a unilateral or a one-stage bilateral total knee arthroplasty were separately randomized to be managed with either aspirin alone or the pulsatile pneumatic plantar-compression device and aspirin. The prevalence of deep venous thrombosis was 27 per cent (twenty-two of eighty-one knees) in the group treated with pneumatic plantar compression compared with 59 per cent (forty-nine of eighty-three knees) in the patients managed with aspirin alone (the control group) (p < 0.001). A significant difference was also noted in the group that had had a unilateral arthroplasty (a prevalence of 27 per cent [eleven of forty-one knees] in the group treated with pneumatic plantar compression, compared with 67 per cent [twenty-six of thirty-nine knees] in that treated with aspirin alone; p < 0.006) and in the group that had had a one-stage bilateral procedure (a prevalence of 28 per cent [eleven of forty knees] in the group treated with pneumatic plantar compression, compared with 52 per cent [twenty-three of forty-four knees] in that treated with aspirin alone; p < 0.03). No proximal thrombi were noted in any patient who used the pulsatile pneumatic plantar-compression device, while the prevalence of proximal thrombosis in the popliteal or femoral veins was 14 per cent (twelve of eighty-three knees) in the group treated with aspirin alone (p < 0.0003). In the group treated with a unilateral procedure and aspirin alone the prevalence of proximal thrombosis was 13 per cent (five of thirty-nine knees; p < 0.02), while in the group treated with a bilateral procedure and aspirin alone it was 16 per cent (seven of forty-four knees; p < 0.01). Only in the patients who had had a unilateral procedure was use of the compression device associated with significantly less edema postoperatively than was use of aspirin alone. The change between the preoperative and postoperative circumferences of the thigh and leg was significantly less (9 +/- 4.1 millimeters [mean and standard deviation] less for the thigh [p < 0.01] and 6 +/- 3.9 millimeters less for the leg [p < 0.049]) with the compression device than with aspirin alone. In addition, there was significantly less mean drainage (98 +/- 61.1 milliliters) in the group treated with a unilateral procedure and pneumatic compression, compared with that treated with a unilateral procedure and aspirin alone (p < 0.041). An internal timer of the compression device was used to assess the compliance of the patient with use of the device, and a relationship between deep venous thrombosis and the total duration of treatment with the device was found. The patients in whom deep venous thrombosis did not develop used the device for a mean of 96 +/- 23.4 hours (range, sixty to 164 hours) postoperatively, or 19.2 +/- 5.1 hours a day, while those in whom thrombosis developed used it for a mean of 67 +/- 21.1 hours (range, twenty-six to 101 hours), or 13.4 +/- 4.3 hours a day (p < 0.001). No untoward effects were noted in any patient who used the device. This study confirms the safety and efficacy of pulsatile pneumatic plantar compression and aspirin compared with aspirin alone and supports the use of mechanical compression for prophylaxis against deep venous thrombosis and for reduction of edema in patients who have had a total knee arthroplasty. In addition, we found a direct relationship between compliance with the use of this device and its efficacy in reducing deep venous thrombosis.

Use of preoperatively deposited autologous blood for total knee replacement.

The efficacy of obviating homologous blood transfusion by an autologous blood program was investigated prospectively in a series of patients undergoing total knee replacement. Seventy-nine patients who underwent 110 consecutive total knee replacement operations (66 unilateral and 22 one-stage bilateral procedures) from 1986 to 1990 were studied. All patients who had elective procedures (86 of the 88 procedures) were encouraged to donate autologous blood prior to surgery if there were no medical contraindications. Seventy-six percent of the elective procedures (65 of 86) were done in patients who deposited autologous blood preoperatively. Homologous transfusion was required after only two of these 65 procedures (3%) in patients who predeposited autologous blood. This frequency of homologous transfusion was an order of magnitude lower than the frequency of homologous transfusion (35%) after procedures in patients who did not predeposit blood. Overall, 89% of the entire series of 88 procedures were performed in patients who received only autologous blood and 94% of the total volume of blood given after these 88 procedures was autologous. The Cell Saver was successful in salvaging an average of 287 mL of red blood cells per procedure after 36 procedures, but was not successful in saving blood after 29 others. The authors conclude that preoperatively deposited autologous blood is effective in reducing the need for homologous transfusion to patients who undergo elective total knee replacement.

Complications and pseudocomplications after Lich-Grégoir antireflux plasty

With exact diagnosis and correct surgical technique, the Lich-Grégoir anti-reflux plasty is safe and complications are few--reflux recurrences are rare. The only serious complication is neurogenic bladder voiding disturbance, which has been observed in some cases after one-stage bilateral procedure and excessive mobilization of the bladder neck. Postoperative ureteral obstructions of the urine flow, generally due to oedemas, are thus temporary. They can be regarded as pseudocomplications.

Anterior transperitoneal approach to the upper urinary tract with one-stage bilateral procedure.

A total of 109 unilateral and 4 bilateral upper urinary tract conditions were treated surgically from 1975 to 1985 by the anterior transverse transperitoneal approach; 26 of these were malignant conditions and 87 were benign. The approach gives good access to the kidney, its pedicle and the upper ureter. There is no increased risk of peritonitis or paralytic ileus due to urinary leak. One-stage bilateral surgical procedures were performed in 4 cases. There was no added risk to the patients. It allows both kidneys to recover simultaneously and provides the opportunity of examining the other intra-abdominal organs.

One-stage Versus Two-stage Bilateral Autophor Ceramic Total Hip Arthroplasty

Noncemented autophor ceramic total hip arthroplasty (ACTHA) has been developed in recent years for treatment of advanced hip diseases. Bilateral ACTHAs were routinely performed in two operations at a four- to six-month interval. There have been no reported series of one-stage bilateral ACTHAs. In this retrospective study, the authors compared 20 patients who had bilateral one-stage ACTHAs with 15 patients who had similar bilateral arthroplasties in two stages. The study revealed no significant differences in estimated intraoperative blood loss, postoperative hemovac drainage, total amount of blood transfusion, intra- or postoperative complications, or postoperative functional results in the two groups. There was no difference in achieving prosthesis stability by interface bone growth, in spite of a significant difference in weight-bearing status during the immediate postoperative period. The one-stage bilateral procedure, however, offered advantages over two-stage bilateral procedures, including shorter length of hospital stay (18 days versus 27 days), shorter operative time (148 minutes versus 245 minutes), shorter period of disability (86 days versus 202 days), and reduced economic costs (about 10% less). There was no increase in the risk of morbidity or mortality in the one-stage bilateral group. In selected cases, one-stage bilateral ACTHA would be preferable.

Surgical Correction of Large Length Discrepancies in the Lower Extremities of Children and Adults

The procedures used to correct large discrepancies in the lengths of the lower extremities are described and the results in twenty consecutive patients are reported. It is concluded that discrepancies of up to twenty centimeters can be corrected surgically so that the patient can wear normal shoes. As much as ten centimeters of correction can be achieved by a one-stage bilateral procedure without excessive risk, provided certain technical precautions are strictly observed. Lengthening of the tibia up to six centimeters is safe even in young adults if a decortication two-stage technique is used. Varus and valgus deformities of the knee and femoral neck must be corrected, sometimes repeatedly during the growth period whenever sufficient angulation develops. The results in twenty patients, six to thirty-three years old, whose discrepancies ranged from seven to 22.6 centimeters, are reported.